Sponsor Pipeline

Bausch Health Americas, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
17
Active Trials
6
Recruiting
3
Phase 3
4
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-14 NCT07285785
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute…
Trial sites expanded: 5 -> 10 locations
2026-07-30 NCT07524946
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Recruitment opened
2026-07-30 NCT07524946
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Trial sites expanded: 0 -> 15 locations
2026-07-23 NCT07428538
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With…
Trial sites expanded: 48 -> 84 locations
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-23 NCT07723924 This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study… Phase 2 Active, Not Recruiting
Active Trials by Phase
Phase 4
7
Phase 3
3
Phase 2
1
Not specified
6
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT03987763 A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With… Psoriasis Recruiting
NCT04314375 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide… Ulcerative Colitis Recruiting
NCT07524946 Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo Acne Vulgaris Recruiting
NCT07285785 Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute… Diarrhea Recruiting
NCT03240809 An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics… Psoriasis Active, Not Recruiting
NCT02129751 Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major… Major Depressive Disorder Not Yet Recruiting
NCT05976802 Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide… Ulcerative Colitis Not Yet Recruiting
Phase 3
NCT07428538 Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With… Hepatitis Recruiting
NCT05071716 Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy… Hepatic Encephalopathy Active, Not Recruiting
NCT05297448 Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With… Hepatic Encephalopathy Active, Not Recruiting
Phase 2
NCT07723924 This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study… Functional Constipation (FC) Active, Not Recruiting
Not specified
NCT07187297 A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX… Wrinkle Recruiting
NCT00568997 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus Atopic Dermatitis Active, Not Recruiting
NCT03254667 LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis Psoriasis Enrolling by Invitation
NCT05132231 Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the… Psoriasis Active, Not Recruiting
NCT07205107 Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian… Acne Vulgaris Active, Not Recruiting
NCT07214272 A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing Skin Resurfacing Active, Not Recruiting
Disease Areas
Get alerts when Bausch Health Americas, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free